The Mark Foundation for Cancer Research Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4
- Investments
-
14
- Portfolio
-
7
- Exits
-
4
The Mark Foundation for Cancer Research General Information
Company Description
Founded in 2015, The Mark Foundation for Cancer Research is a venture capital firm based in New York, New York. The firm seeks to invest in companies operating in the cancer, biology, healthcare, and diagnostics sectors.
Business Details
Website
www.themarkfoundation.orgYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 1350 6th Avenue
- New York, NY 10019
- United States
The Mark Foundation for Cancer Research Investments (14)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| GenXys | 01-Feb-2025 | Seed Round | Other Healthcare Technology Systems | Generating Revenue | ||
| Hyku Biosciences | 12-Nov-2024 | Drug Discovery | Generating Revenue | |||
| Accent Therapeutics | 20-Dec-2023 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Vicinitas Therapeutics | 28-Jul-2022 | Drug Discovery | Generating Revenue | |||
| The Jackson Laboratory | 20-Dec-2021 | Laboratory Services (Healthcare) | Generating Revenue | |||
| Immunitas Therapeutics | 18-Aug-2021 | Drug Discovery | Generating Revenue | |||
| Interius BioTherapeutics | 18-May-2021 | Drug Delivery | Clinical Trials - Phase 1 | |||
| CRCbioscreen | 17-Mar-2021 | Diagnostic Equipment | Clinical Trials - General | |||
| Interius BioTherapeutics | 05-Aug-2020 | Seed Round | Drug Delivery | Clinical Trials - Phase 1 | ||
| C2i Genomics | 24-May-2020 | Early Stage VC | Decision/Risk Analysis | Generating Revenue |
The Mark Foundation for Cancer Research Exits (4)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Immunitas Therapeutics | 12-May-2026 | Merger/Acquisition | |
| Interius BioTherapeutics | 14-Oct-2025 | ||
| C2i Genomics | 05-Feb-2024 | Merger/Acquisition | |
| GRAIL | 18-Aug-2021 | Merger/Acquisition |
The Mark Foundation for Cancer Research Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
The Mark Foundation for Cancer Research Co-Investors (24)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Droia Ventures | 3 |
|
|
||
| GV |
|
|
|||
| Atlas Venture |
|
|
|||
| Johnson & Johnson JJDC |
|
|
|||
| The Column Group |
|
|
The Mark Foundation for Cancer Research FAQs
-
What is The Mark Foundation for Cancer Research?
Founded in 2015, The Mark Foundation for Cancer Research is a venture capital firm based in New York, New York.
-
When was The Mark Foundation for Cancer Research founded?
The Mark Foundation for Cancer Research was founded in 2015.
-
Where is The Mark Foundation for Cancer Research headquartered?
The Mark Foundation for Cancer Research is headquartered in New York, NY.
-
How many investments has The Mark Foundation for Cancer Research made?
The Mark Foundation for Cancer Research has made 14 investments.
-
What has The Mark Foundation for Cancer Research invested in?
The Mark Foundation for Cancer Research has made numerous investments in companies like GenXys, Hyku Biosciences, and Accent Therapeutics within the Healthcare Technology Systems and Drug Discovery industries.
-
What has The Mark Foundation for Cancer Research invested in recently?
The Mark Foundation for Cancer Research's latest investment was on 01-Feb-2025 in GenXys, a company within the Healthcare Technology Systems industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
